LogicBio Therapeutics, Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/795ab35c-7130-4cdf-8c0a-6f3ca9db3748/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-39.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-008771 |
| FY 2020 | $-31.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-013165 |
| FY 2019 | $-41.0M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-011170 |
| FY 2018 | $-17.9M | 2018-01-01 – 2018-12-31 | evidence 0001193125-19-094593 |
| FY 2017 | $-5.9M | 2017-01-01 – 2017-12-31 | evidence 0001193125-19-094593 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).